Roger Mack Hinson

Insider

First SEC filing: Sept. 29, 2020 · Latest: Sept. 29, 2020

On this page

Insider at

0 buys (P) 0 sells (S) Net: $0 + 4 non-open-market transactions below last 12 months, based on the transactions shown below

Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted

4 other filings hidden

Date	Ticker	Code	Shares	Price	Value	Owned after	Δ own	A/D	vs now
March 1, 2022	MD	F	10,244	$23.47	$240,427	109,457 Direct	-8.56%	Disposed	11.5% (price as of 2026-08-21)
Nov. 10, 2021	MD	S 10b5-1	8,800	$28.38	$249,744	107,391 Direct	-7.57%	Disposed	-7.8% (price as of 2026-08-21)
Aug. 10, 2021	MD	S 10b5-1	8,799	$32.35	$284,648	116,129 Direct	-7.04%	Disposed	-19.1% (price as of 2026-08-21)
March 1, 2021	MD	F	6,244	$24.43	$152,541	124,800 Direct	-4.76%	Disposed	7.1% (price as of 2026-08-21)
March 1, 2021	MD	A	30,613	—	—	130,862 Direct	+30.54%	Acquired	(price as of 2026-08-21)
March 1, 2021	MD	A	30,612	—	—	100,249 Direct	+43.96%	Acquired	(price as of 2026-08-21)

P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding

Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.

Securities held when first becoming an insider, per SEC Form 3.

Date	Ticker	Security	Shares	Ownership
Sept. 29, 2020	MD	Common Stock	53,358	Direct
Sept. 29, 2020	MD	Common Stock	16,279	Direct
Sept. 29, 2020	MD	Employee Stock Option (right to buy)→ Common Stock (144,000)	144,000	Direct

Matched by name from proxy statements (DEF 14A) — verify against the filing.

M.D. President, Pediatrix and Obstetrix Medical Group(13)

Fiscal year	Salary	Bonus	Stock awards	Option awards	Non-equity incentive	Pension change	Other	Total
2020	$432,833	—	—	—	$550,000	—	$258,798	$2,913,219

Figures from the Summary Compensation Table of the company's proxy statement (DEF 14A). Compensation is not a recommendation.